Get the Blueprint

Manufacturing NewsTEG DailyNovember 11, 2026

November 11, 2026 · Tippecanoe County · Story 5 of 5

Evonik Produces First GMP Lipid Batch at $220 Million Lafayette Plant

Daniel BurkePublished every day

Evonik announced on November 10 that it manufactured the first pharmaceutical-grade batch of PhytoChol, a non-animal cholesterol ingredient used in lipid nanoparticle drug delivery, at its new Lipid Innovation Center on the Tippecanoe Laboratories site in Lafayette. Full production capacity is targeted for mid-2027. The project carries up to $150 million in federal cost-sharing through BARDA and is expected to add more than 80 jobs to a site that already employs about 650 people.

Evonik's head of drug delivery says the Lafayette plant will exceed the combined output of the company's two German facilities, making Tippecanoe the largest single source of GMP pharmaceutical cholesterol in Evonik's network. That concentration means a disruption at one site could bottleneck multiple drug programs at once. Part of the plant's business case rests on a 10-year government priority-access clause tied to a declared public health emergency, but HHS wound down BARDA's mRNA vaccine funding in August 2025, canceling 22 grants worth about $500 million. The manufacturing award itself appears structurally separate from that pullback, but it weakens the broader demand assumption behind the "pandemic preparedness" rationale.

Impact
Evonik's head of drug delivery, Paul Spencer, says the Lafayette plant will exceed the combined capacity of its Dossenheim and Hanau facilities in Germany, making Tippecanoe the swing producer for GMP pharmaceutical cholesterol globally, a concentration risk since any single-site disruption could now bottleneck multiple LNP drug programs at once. The bigger under-reported wrinkle: the facility's business case rests partly on a 10-year government priority-access clause during a declared public health emergency, but HHS wound down BARDA's mRNA vaccine investments in August 2025, canceling 22 grants worth about $500 million, weakening the demand assumption behind the 'pandemic preparedness' backstop even though this specific manufacturing-infrastructure award appears structurally insulated.
Watch
Progress toward the mid-2027 full-capacity target and any further federal policy shifts affecting BARDA's mRNA-platform funding.
For the huddle

If Tippecanoe becomes the world's swing producer of GMP pharmaceutical cholesterol, do we know whether any of our pharma or biotech customers are relying on that single site, and how durable is the federal backstop given BARDA's pullback from mRNA programs?

Hallador's turbine inspection and escrow release are due in December, and any spec gap there could push the 2028 in-service date right when new Indiana gas capacity is needed, so track both timelines rather than assuming either holds.

Sources

  1. Evonik Produces First GMP Lipids at Indiana Facility · contractpharma.com

Earlier coverage

From the brief, November 11, 2026

  1. AES Indiana's Rate Fight Could Reset Indiana Manufacturing Power Costs Statewide
  2. Hallador Targets Year-End Decision on 460 MW Turtle Creek Gas Plant
  3. Astemo Invests $11 Million in Muncie HEV Manifold Line
  4. NIPSCO Settlements Cut Gas Efficiency Programs for 800,000 Customers
  5. Evonik Produces First GMP Lipid Batch at $220 Million Lafayette Plant

The whole day’s brief →

This story

Tippecanoe CountyPlants Capex

Related

Manufacturers Energy Grant Program

Free for Tippecanoe County manufacturers

Tippecanoe County manufacturers receive free, ongoing energy auditing and cost control that reduces their energy bills and keeps them low, month after month. Every line item checked and validated, every opportunity found comes with a step-by-step guide to capture it.

Claim your GrantCheck out the program

EDCs: sponsor this program and it carries your organization's name For economic developers →